ArticleThe Journal of clinical investigation2008

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.

Marta Guix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.